Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
McKesson
McKinsey
Dow
AstraZeneca

Last Updated: January 20, 2020

DrugPatentWatch Database Preview

Patent: 9,669,026

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for Patent: 9,669,026
Title:Use of levocetirizine and montelukast in the treatment of autoimmune disorders
Abstract: The embodiments described herein include methods and formulations for treating autoimmune disorders. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
Inventor(s): May; Bruce Chandler (Santa Barbara, CA)
Assignee: INFLAMMATORY RESPONSE RESEARCH, INC. (Santa Barbara, CA)
Application Number:14/831,339
Patent Claims:see list of patent claims

Details for Patent 9,669,026

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20   Start Trial INFLAMMATORY RESPONSE RESEARCH, INC. (Santa Barbara, CA) 2033-03-13 RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 003 1991-02-20   Start Trial INFLAMMATORY RESPONSE RESEARCH, INC. (Santa Barbara, CA) 2033-03-13 RX search
Amgen NEUPOGEN filgrastim VIAL 103353 002 1991-02-20   Start Trial INFLAMMATORY RESPONSE RESEARCH, INC. (Santa Barbara, CA) 2033-03-13 RX search
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20   Start Trial INFLAMMATORY RESPONSE RESEARCH, INC. (Santa Barbara, CA) 2033-03-13 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Harvard Business School
Moodys
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.